Kiffik Biomedical
The AI engine Fit Assessment
BetaThe company will be attending the 2024 Health Tech Forward Event
Blurb
Kiffik Biomedical developed a novel technology that transmits health data.
HQ Location
United States
Founded
2018
Employees
11 - 50
Total funding raised
$2.16M
Last Funding Event
Series A, $830.00K, June 24, 2022
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Developer of an interstitial fluid technology designed to expand the understanding of diseases. The company's technology can be applied as a sampling and monitoring tool for drug research in preclinical and clinical trials as an alternative medium for bio-derivative production, enabling medical researchers, and biopharmaceuticals to find new possibilities in preventive medicine and empower patients to manage their health proactively.